Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Susceptibility Testing of Colistin for Acinetobacter baumannii: How Far Are We from the Truth?

5 Jan 2021

Abstract excerpt

Acinetobacter baumannii is involved in life-threatening nosocomial infections, mainly in the intensive care units (ICUs), and often colistin may represent the last therapeutic opportunity. The susceptibility to colistin of 51 epidemiologically typed A. baumannii strains isolated in 2017 from clinical samples of patients hospitalized in the ICU of a tertiary care academic hospital was investigated. All isolates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Pharmaceutical and Antibiotic Environmental Impacts

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33466515
DOI: 10.3390/antibiotics10010048

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Susceptibility Testing of Colistin for Acinetobacter baumannii: How Far Are We from the Truth?PMID 33466515Read ↗

Prevalence of Genes Involved in Colistin Resistance in Acinetobacter baumannii: First Report from Iraq.Semantic proximity Read ↗

First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in EgyptSemantic proximity Read ↗

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).Semantic proximity Read ↗

Molecular Characterization of Colistin Resistance Determinants in Clinical and Patient-Environmental Multidrug-Resistant Acinetobacter baumanniiSemantic proximity Read ↗

Colistin Resistance in Environmental Isolates of Acinetobacter baumannii.Semantic proximity Read ↗

Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons.Semantic proximity Read ↗

Trends in Colistin Resistance and Multidrug-Resistant Phenotypes Among Gram-Negative Bacilli: A Retrospective AnalysisSemantic proximity Read ↗

Molecular Characterization of Carbapenem/Colistin-Resistant Acinetobacter baumannii Clinical Isolates from Egypt by Whole-Genome SequencingSemantic proximity Read ↗

Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumanniiSemantic proximity Read ↗

Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and EpidemiologySemantic proximity Read ↗

A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.Semantic proximity Read ↗

Colistin Resistance Mechanism and Management Strategies of Colistin-Resistant <em>Acinetobacter baumannii</em> InfectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.